Compounds > tretazicar

Page last updated: 2024-08-26

tretazicar and Colonic Neoplasms

tretazicar has been researched along with Colonic Neoplasms in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (12.50)	18.7374
1990's	2 (25.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dubois, L; Ehsaan, M; Heap, JT; Knox, R; Kubiak, AM; Kuehne, SA; Lambin, P; Minton, NP; Paesmans, K; Theys, J; Van Mellaert, L	1
Byrne, WL; Cummins, J; Lehouritis, P; McCarthy, FO; Murphy, CT; Reid, G; Stanton, M; Tangney, M; Urbaniak, C	1
Ackerley, DF; Copp, JN; Patterson, AV; Prosser, GA; Smaill, JB; Syddall, SP; Williams, EM; Wilson, WR	1
Chen, MJ; Fuerer, C; Iggo, R; Lukashev, AN; Searle, P	1
James, ND; Latham, JP; Mautner, V; Searle, PF	1
Sugget, N; Walton, MI; Workman, P	1
Baer, J; Bagshawe, KD; Sunters, A	1
Donaldson, J; Morgan, JE; Talbot, K; Twentyman, PR; Workman, P; Wright, KA	1

Other Studies

8 other study(ies) available for tretazicar and Colonic Neoplasms

Article	Year
Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo. Oncotarget, 2014, 04-15, Volume: 5, Issue:7 Topics: Animals; Antineoplastic Agents; Aziridines; Biological Therapy; Carcinoma; Clostridium; Colonic Neoplasms; Mice; Neisseria meningitidis; Nitroreductases; Organisms, Genetically Modified; Plasmids; Prodrugs; Protein Engineering; Spores, Bacterial; Xenograft Model Antitumor Assays	2014
Local bacteria affect the efficacy of chemotherapeutic drugs. Scientific reports, 2015, Sep-29, Volume: 5 Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Cladribine; Colonic Neoplasms; Deoxycytidine; Escherichia coli; Female; Gemcitabine; Injections, Intralesional; Injections, Subcutaneous; Listeria; Mice; Neoplasm Transplantation; Skin; Treatment Outcome; Vidarabine	2015
Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954. Biochemical pharmacology, 2010, Mar-01, Volume: 79, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Escherichia coli; Escherichia coli Proteins; Gene Silencing; Genetic Therapy; Humans; Kinetics; Nitroreductases; Prodrugs; SOS Response, Genetics; Transfection; Tumor Cells, Cultured	2010
Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954. Human gene therapy, 2005, Volume: 16, Issue:12 Topics: Adenoviridae; Animals; Antibiotics, Antineoplastic; Aziridines; Cell Line; Colonic Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Escherichia coli Proteins; Fibroblasts; Genetic Therapy; Genetic Vectors; Humans; Male; Mice; Mice, Nude; Nitroreductases; Oncolytic Viruses; Prodrugs; Sirolimus; Transduction, Genetic	2005
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Cancer research, 2000, Jan-15, Volume: 60, Issue:2 Topics: Adenoviridae; Androgens; Antineoplastic Agents; Aziridines; Cell Survival; Colonic Neoplasms; Coloring Agents; Cytomegalovirus; Enhancer Elements, Genetic; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Jurkat Cells; Kinetics; Luciferases; Luminescent Proteins; Male; Oxazines; Polymerase Chain Reaction; Prodrugs; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins; Tissue Kallikreins; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Xanthenes	2000
The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins. International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:4 Topics: Animals; Antineoplastic Agents; Aziridines; Carcinoma 256, Walker; Cell Hypoxia; Colonic Neoplasms; Humans; In Vitro Techniques; Indolequinones; Indoles; Mitomycin; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Prodrugs; Rats; Tirapazamine; Triazines	1992
Cytotoxicity and activation of CB1954 in a human tumour cell line. Biochemical pharmacology, 1991, May-01, Volume: 41, Issue:9 Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; NAD; Nitroreductases; Prodrugs; Tumor Cells, Cultured	1991
CB 1954 revisited. II. Toxicity and antitumour activity. Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:1 Topics: Animals; Aziridines; Azirines; Colonic Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Humans; Lomustine; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma, Experimental	1986